Goldman, JPM Block China, Hong Kong Investors From SpaceX IPO
SpaceX’s underwriters Goldman Sachs and JPMorgan have barred investors from China and Hong Kong, citing regulatory and compliance concerns. The company plans to sell about 555.6 million shares at $135 each, raising roughly $75 billion and valuing the firm near $1.8 trillion. JPMorgan CEO Jamie Dimon is leading a live roadshow for ultra‑wealthy clients across 90 U.S. locations to generate demand. Excluding Chinese and Hong Kong investors removes a sizable source of capital from what could be the world’s largest IPO.
Weekly Wrap: SpaceX IPO vs Spectrum Reality
SpaceX plans to list on Nasdaq by offering less than 5% of its equity, with 30% of those shares earmarked for retail investors—a stark contrast to the typical 10% allocation. A new Nasdaq fast‑track rule will force Nasdaq‑100 index funds...
Nio's Battery Operator Mirattery Continues Asset Securitization Push with New ABS Issuance
Mirattery, the battery‑asset manager for Nio, launched a new green asset‑backed securities (ABS) tranche on the Shenzhen Stock Exchange, raising 1 billion yuan (≈ $148 million). The issuance is part of a 3 billion yuan (≈ $443 million) shelf‑registration quota, the exchange’s first green sci‑tech power‑battery...
Restructuring Venezuela’s Sovereign Debt and Rebuilding Its Economy Post-Maduro
Investors cheered the early‑January U.S. capture of Nicolás Maduro, sending Venezuela sovereign and PDVSA bonds sharply higher as a debt‑restructuring window seemed to open. The government has now announced a formal restructuring process and hired external advisers, but the country...
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
Gilead Sciences and Lakefront Biotherapeutics have completed Gilead’s $1.675 billion acquisition of Ouro Medicines, adding the BCMA×CD3 T‑cell engager gamgertamig to Gilead’s inflammation portfolio. The drug, which holds FDA Fast Track and Orphan designations for autoimmune hemolytic anemia and immune thrombocytopenia,...
The IPO Buzz: INNIO (INIO) Jumps in NASDAQ Debut After Big Upsizing
INNIO Holding debuted on Nasdaq at $31 per share, a 14.8% premium over its $27 IPO price, after upsizing the offering to 90 million shares and raising roughly $2.43 billion. The secondary‑sale IPO, led by Goldman Sachs, J.P. Morgan and Morgan Stanley,...
InsideArbitrage Event Driven Monitor – June 4, 2026
The June 4 InsideArbitrage Event Driven Monitor highlights several headline‑making developments: Sherwin‑Williams and Nippon Paint abandon their joint cash bids for AkzoNobel, while Cross Country Healthcare files a preliminary proxy for its pending merger with Knox Lane, targeting a third‑quarter 2026...
Goldman: The IPO Pop Trap — The Margin For Error Is Shrinking ( Chart Pack)
Goldman Sachs warns that the IPO market’s margin for error is tightening as valuations, AI‑centric hype, and yield expectations converge. Even strong earnings are no longer sufficient; only truly exceptional news can keep prices stable. The research notes that while...
Long Table Growth Corp. (LTGRU) Prices $150M IPO
Long Table Growth Corp. (LTGRU) priced its $150 million initial public offering and will begin trading on Nasdaq under the ticker LTGRU on June 4, 2026. The SPAC aims to acquire a company in fintech, industrial technology, or the energy‑transition space. Led by...
The IPO Buzz: SpaceX (SPCX Proposed) Sets $135/Share IPO Price to Raise $75 Billion
SpaceX filed its S‑1/A on June 3, setting the IPO price at $135 per share and targeting a $75 billion raise. The offering would consist of 555.56 million shares, valuing the company at roughly $1.8 trillion post‑pricing. Goldman Sachs and Morgan Stanley are...
Google Traffic Down. 7 Solutions From 11 Years of Selling Media Companies.
Songbird.Group, after 11 years of brokering media exits, announced it will stop acquiring any new businesses that rely primarily on Google organic traffic, citing a universal decline in Google Analytics data across its portfolio. The firm’s internal analysis shows 100%...
AmperCap Acquisition Company (APMCU) Prices $125M IPO
AmperCap Acquisition Company (APMCU) priced its $125 million initial public offering, with units slated to begin trading on Nasdaq on June 3, 2026. The SPAC will target middle‑market firms that have strategic ties to the United States or Mexico and possess scalable business...
Aeon Acquisition I Corp. (AESPU) Prices $125M IPO
Aeon Acquisition I Corp. priced its $125 million initial public offering and will begin trading on Nasdaq under the ticker AESPU on June 3, 2026. The SPAC is targeting a merger with a sports‑related company or an adjacent business, emphasizing opportunities in the...
New SPACs: Wilco 63 Corporation (WLCOU), Bridge III Acquisition Limited (BDDDU) File for IPOs
Wilco 63 Corporation (ticker WLCOU) and Bridge III Acquisition Limited (ticker BDDDU) have each filed Form S‑1 to launch new special purpose acquisition companies. Both filings disclose plans to raise roughly $150 million and $200 million respectively, with capital earmarked for future merger opportunities. The...
Forbright (FRBT) IPO Deck
Forbright, a digital‑first financial services firm and commercial bank, has released its IPO deck ahead of a planned public offering. The company focuses on providing banking and credit solutions to U.S. middle‑market businesses and consumers through a technology‑driven platform. The...